Related references
Note: Only part of the references are listed.Aerodynamics Effect of Holes in UAV Wings Modified for VTOL Capability
Laith S. Sawaqed et al.
DRONE SYSTEMS AND APPLICATIONS (2022)
Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015
Faith G. Davis et al.
NEURO-ONCOLOGY (2020)
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma
Bingtao Tang et al.
CLINICAL CANCER RESEARCH (2020)
High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
Ana Ricobaraza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Delivery and Biosafety of Oncolytic Virotherapy
Lizhi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
E. Antonio Chiocca et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
Noemi Garcia-Romero et al.
CELLS (2020)
Current State of Immunotherapy for Treatment of Glioblastoma
Tresa McGranahan et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Therapeutic targeting of trained immunity
Willem J. M. Mulder et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
Carlos Velasquez et al.
JOURNAL OF ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro et al.
CLINICAL CANCER RESEARCH (2019)
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Juri Kiyokawa et al.
ONCOLYTIC VIROTHERAPY (2019)
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
Yisel Rivera-Molina et al.
NEURO-ONCOLOGY ADVANCES (2019)
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma
John A. Barrett et al.
CANCER GENE THERAPY (2018)
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma
Hiroshi Nakashima et al.
CLINICAL CANCER RESEARCH (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
Adel Samson et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory
Mohammed G. Ghonime et al.
TRANSLATIONAL ONCOLOGY (2018)
Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
Jovan Nikolic et al.
NATURE COMMUNICATIONS (2018)
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
Yang Bai et al.
SCIENTIFIC REPORTS (2018)
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Chase Burton et al.
ONCOLYTIC VIROTHERAPY (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
Assia L. Angelova et al.
VIRUSES-BASEL (2017)
Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo
Yun-Ju Lai et al.
ONCOTARGET (2017)
Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer
Anwen Howells et al.
FRONTIERS IN ONCOLOGY (2017)
TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma.
Ahmed Idbaih et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
Hong Jiang et al.
CANCER RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma
Alexandra Pisklakova et al.
NEURO-ONCOLOGY (2016)
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera et al.
PLOS ONE (2016)
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Gila Kazimirsky et al.
STEM CELL RESEARCH & THERAPY (2016)
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Vaccinia virus, a promising new therapeutic agent for pancreatic cancer
Chadwan Al Yaghchi et al.
IMMUNOTHERAPY (2015)
Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy
Jordi Martinez-Quintanilla et al.
MOLECULAR THERAPY (2015)
Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector
Guido Wollmann et al.
VIROLOGY (2015)
Oncolytic parvoviruses: from basic virology to clinical applications
Antonio Marchini et al.
VIROLOGY JOURNAL (2015)
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Carolien A. Koks et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schoenfeld et al.
MOLECULAR THERAPY (2015)
Advances in the design and development of oncolytic measles viruses
Brian Hutzen et al.
ONCOLYTIC VIROTHERAPY (2015)
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
James M. Markert et al.
MOLECULAR THERAPY (2014)
The role of cancer stem cells in glioblastoma
Swetha J. Sundar et al.
NEUROSURGICAL FOCUS (2014)
Newcastle disease virus: Current status and our understanding
Ketan Ganar et al.
VIRUS RESEARCH (2014)
Newcastle Disease Virus Interaction in Targeted Therapy against Proliferation and Invasion Pathways of Glioblastoma Multiforme
Jafri Malin Abdullah et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Chemotherapy and oncoyic virotherapy: advanced tactics in the war against cancer
Andrew Nguyen et al.
FRONTIERS IN ONCOLOGY (2014)
Poliomyelitis: Historical Facts, Epidemiology, and Current Challenges in Eradication
Man Mohan Mehndiratta et al.
NEUROHOSPITALIST (2014)
Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults
Kimberly P. Kicielinski et al.
MOLECULAR THERAPY (2014)
Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
Patricia Bach et al.
CANCER RESEARCH (2013)
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumorbased orthotopic xenograft mouse models of pediatric glioma
Zhigang Liu et al.
NEURO-ONCOLOGY (2013)
Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo
Henry Ogbomo et al.
PLOS ONE (2013)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
Karsten Geletneky et al.
BMC CANCER (2012)
Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates
Guido Wollmann et al.
CANCER JOURNAL (2012)
Effective Radiovirotherapy for Malignant Gliomas by Using Oncolytic Measles Virus Strains Encoding the Sodium Iodide Symporter (MV-NIS)
Mateusz Opyrchal et al.
HUMAN GENE THERAPY (2012)
LuIII Parvovirus Selectively and Efficiently Targets, Replicates in, and Kills Human Glioma Cells
Justin C. Paglino et al.
JOURNAL OF VIROLOGY (2012)
Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis
Brooke Harmon et al.
JOURNAL OF VIROLOGY (2012)
Replication-competent Herpes Simplex Virus Retargeted to HER2 as Therapy for High-grade Glioma
Eleonora Gambini et al.
MOLECULAR THERAPY (2012)
AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
O. L. Chinot et al.
ADVANCES IN THERAPY (2011)
Oncolytic poliovirus against malignant glioma
Christian Goetz et al.
FUTURE VIROLOGY (2011)
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor
J-C Tseng et al.
CANCER GENE THERAPY (2010)
Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection
Karsten Geletneky et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
Guido Wollmann et al.
JOURNAL OF VIROLOGY (2010)
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
Juan J. Rojas et al.
MOLECULAR THERAPY (2010)
Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
Jayson Hardcastle et al.
MOLECULAR THERAPY (2010)
Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for Glioblastoma
Darnell T. Josiah et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models
Karsten Geletneky et al.
NEURO-ONCOLOGY (2010)
Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus
J. Puhlmann et al.
ONCOGENE (2010)
Initial Testing of the Replication Competent Seneca Valley Virus (NTX-010) by the Pediatric Preclinical Testing Program
Christopher L. Morton et al.
PEDIATRIC BLOOD & CANCER (2010)
Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
Xue Qing Lun et al.
CLINICAL CANCER RESEARCH (2009)
A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
J. J. Rojas et al.
GENE THERAPY (2009)
Engineered herpes simplex viruses efficiently infect and kill CD133+human glioma xenograft cells that express CD111
Gregory K. Friedman et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
Xiaoyi Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Peripheral Immunization Blocks Lethal Actions of Vesicular Stomatitis Virus within the Brain
Koray Ozduman et al.
JOURNAL OF VIROLOGY (2009)
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre- and Post-tumor Resection for Recurrent GBM
James M. Markert et al.
MOLECULAR THERAPY (2009)
Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma
M. M. Zulkifli et al.
NEUROLOGICAL RESEARCH (2009)
Adenovirus receptors and their implications in gene delivery
Anurag Sharma et al.
VIRUS RESEARCH (2009)
Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain
Koray Ozduman et al.
JOURNAL OF NEUROSCIENCE (2008)
Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic Phenotype
Elena Y. Dobrikova et al.
MOLECULAR THERAPY (2008)
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas
Peter Forsyth et al.
MOLECULAR THERAPY (2008)
Armed oncolytic herpes simplex viruses for brain tumor therapy
Tomoki Todo
CELL ADHESION & MIGRATION (2008)
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice
David Cooper et al.
JOURNAL OF VIROLOGY (2008)
Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
P. Seshidhar Reddy et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M. Alonso et al.
CANCER RESEARCH (2007)
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
A. C. Shah et al.
GENE THERAPY (2007)
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas
Georgia Paraskevakou et al.
MOLECULAR THERAPY (2007)
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells
Matteo Di Piazza et al.
JOURNAL OF VIROLOGY (2007)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors
Claire Marie Filone et al.
VIROLOGY (2006)
Effects of intravenously administered recombinant vesicular stomatitis virus (VSVΔM51) on Multifocal and invasive gliomas
XueQing Lun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells
Anette Abschuetz et al.
CELL AND TISSUE RESEARCH (2006)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates
AM Naik et al.
HUMAN GENE THERAPY (2006)
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas
XQ Lun et al.
CANCER RESEARCH (2005)
The use of oncolytic vaccinia viruses in the treatment of cancer: A new role for an old ally?
SH Thorne et al.
CURRENT GENE THERAPY (2005)
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model
EK Hellums et al.
NEURO-ONCOLOGY (2005)
Targeting human glioblastoma cells: Comparison of nine viruses with oncolytic potential
G Wollmann et al.
JOURNAL OF VIROLOGY (2005)
An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor
H Kambara et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MTH-68/H oncolytic viral treatment in human high-grade gliomas
LK Csatary et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses
J Publicover et al.
JOURNAL OF VIROLOGY (2004)
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
F Wang et al.
NATURE IMMUNOLOGY (2004)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Pathways of cell infection by parvoviruses and adeno-associated viruses
M Vihinen-Ranta et al.
JOURNAL OF VIROLOGY (2004)
Hyaluronan: From extracellular glue to pericellular cue
BP Toole
NATURE REVIEWS CANCER (2004)
Poliovirus receptor CD155-targeted oncolysis of glioma
MK Merrill et al.
NEURO-ONCOLOGY (2004)
Systemic tumor targeting and killing by Sindbis viral vectors
JC Tseng et al.
NATURE BIOTECHNOLOGY (2004)
Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefit
HH Steiner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model
CD Duntsch et al.
JOURNAL OF NEUROSURGERY (2004)
Gene therapy for matignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein
J Zhang et al.
JOURNAL OF GENE MEDICINE (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Drug and gene delivery to the brain: The vascular route
WM Pardridge
NEURON (2002)
Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells
MP Rubio et al.
JOURNAL OF VIROLOGY (2001)
Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: New strategy for vaccine development
EB Flanagan et al.
JOURNAL OF VIROLOGY (2001)
Reovirus as an oncolytic agent against experimental human malignant gliomas
ME Wilcox et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing
T Todo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas
E Galanis et al.
HUMAN GENE THERAPY (2001)
Low-dose vaccinia virus-mediated cytokine gene therapy of glioma
B Chen et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Resistance to Rift Valley fever virus in Rattus norvegicus:: genetic variability within certain 'inbred' strains
M Ritter et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Multicellular resistance: a paradigm for clinical resistance?
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2000)
Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model
B Chen et al.
CANCER GENE THERAPY (2000)
Vesicular stomatitis virus (VSV) therapy of tumors
S Balachandran et al.
IUBMB LIFE (2000)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Share Paper
